Eric H. Schoenstein
Jensen Investment Management
Eric H. Schoenstein Bristol-Myers Squibb Company stake
total: 257
Jensen Investment Management BMY trades
- Total transactions:
- 8
- New positions:
- 1
- Sold out:
- 1
- Added:
- 3
- Reduced:
- 3
- Held since:
- 2015 Q1
- Held for:
- 43 quarters
- Latest activity:
- 2025 Q4
According to 2026 Q2 report, Eric H. Schoenstein doesn't hold any Bristol-Myers Squibb Company (BMY) shares. To date, the estimated cost basis is nearly $64.36 for "buy" trades and estimated average "sell" price is $49.4. Jensen Investment Management first purchased BMY in 2015 Q1, initially acquiring 33,000 shares. Since the initial investment in Bristol-Myers Squibb Company (BMY), Jensen Investment Management has made 7 more transactions.
When did Eric H. Schoenstein sell Bristol-Myers Squibb Company (BMY)?
Eric H. Schoenstein sold off the entire Bristol-Myers Squibb Company (BMY) position in 2025 Q4.
When did Eric H. Schoenstein buy Bristol-Myers Squibb Company (BMY)?
Eric H. Schoenstein first invested in Bristol-Myers Squibb Company (BMY) in 2015 Q1 at the reported quarter-end price of $64.52 per share.
What's the cost basis of Jensen Investment Management's BMY stake?
The estimated cost basis for Bristol-Myers Squibb Company (BMY) stake is around $64.36 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $64.36
- Weighted AVG sell price:
- $49.40
Eric H. Schoenstein's historical trades in Bristol-Myers Squibb Company
8 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2025 Q4
|
0.00%
|
0
|
$45.10
|
|
-100% (-26,475)
|
-0.01%
|
|
2025 Q3
|
0.01%
|
26,475
|
$45.10
|
$1,194,023
|
+0.38% (+100)
|
+0%
|
|
2021 Q2
|
0.01%
|
26,375
|
$66.81
|
$1,762,000
|
-2.94% (-800)
|
-0%
|
|
2019 Q4
|
0.02%
|
$64.18
|
+4.52% (+1,175)
|
|||
|
2018 Q1
|
0.02%
|
$63.27
|
-21.21% (-7,000)
|
|||
|
2016 Q4
|
0.03%
|
$58.45
|
-0.90% (-300)
|
|||
|
2016 Q3
|
0.03%
|
$53.93
|
+0.91% (+300)
|
|||
|
2015 Q1
|
0.03%
|
$64.52
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.